Interactions and undesirable side effects of platelet aggregation inhibitors
García Morillas, M.; Caracuel Ruiz, M.D.; Sánchez de la Cuesta, F.
Medicina Clinica 90(13): 553-555
1988
ISSN/ISBN: 0025-7753 PMID: 3393040 Document Number: 324790
Document emailed within 1 workday
Related Documents
Yamanishi, J.; Sano, H.; Saito, K.; Furuta, Y.; Fukuzaki, H. 1985: Plasma concentrations of platelet-specific proteins in different stages of essential hypertension: interactions between platelet aggregation, blood lipids and age Thrombosis and Haemostasis 54(2): 539-543Nyby, M.D.; Sasaki, M.; Ideguchi, Y.; Wynne, H.E.; Hori, M.T.; Berger, M.E.; Golub, M.S.; Brickman, A.S.; Tuck, M.L. 1996: Platelet lipoxygenase inhibitors attenuate thrombin- and thromboxane mimetic-induced intracellular calcium mobilization and platelet aggregation Journal of Pharmacology and Experimental Therapeutics 278(2): 503-509
Panhuysen, L.H. 1970: Undesirable side effects of LSD administration Nederlands Tijdschrift Voor Geneeskunde 114(17): 723-727
Tscherne, G. 1987: Favorable concomitant effects and undesirable side effects of oral contraceptives Wiener Medizinische Wochenschrift 137(18-19): 450-455
Daghfous, R.; Srairi, S.; el Aidli, S.; Belkahia, C. 1994: Management of undesirable side effects of medications La Tunisie Medicale 72(10): 581-583
Pürschel, W.; Schulmeyer, M. 1980: PUVA therapy and its possible undesirable side-effects Zeitschrift für Hautkrankheiten 55(12): 839-846
Fossati, C.; Fanzio, G. 1985: Undesirable and toxic side effects of medicinal plants La Clinica Terapeutica 112(3): 249-259
Zannino, L.; Salvadori, G. 1979: Platelet aggregation inhibitors. their possible use in pediatric pathology Minerva Pediatrica 31(2): 153-169
Panchenko, V.M.; Vladimirova, A.V.; Pastorova, V.E.; Sukhanova, S.A. 1980: Fibrinolysis and its inhibitors, and platelet aggregation in rheumatism Laboratornoe Delo 11: 671-675
Gastpar, H. 1982: Platelet aggregation inhibitors and cancer metastasis Annales Chirurgiae et Gynaecologiae 71(3): 142-150
Silveira, I.A.; Paulo, L.G.; Miranda, A.L.; Rocha, S.O.; Freitas, A.C.; Barreiro, E.J. 1991: Substituted pyrazolylhydrazones: a new class of platelet aggregation inhibitors Brazilian Journal of Medical and Biological Research 24(9): 947-951
Luo, H.W.; Hu, X.J.; Wang, N.; Ji, J. 1988: Platelet aggregation inhibitors from Salvia miltiorrhiza Bunge Yao Xue Xue Bao 23(11): 830-834
Klimova, E.A.; Timina, V.P. 1986: Probability of occurrence of undesirable effects of drug interactions in the treatment of suppurative meningitis Sovetskaia Meditsina 12: 119-121
Yasunaga, K. 1979: Inhibition of platelet aggregation by platelet inhibitory agents and its relation to their clinical effects Rinsho Byori. Japanese Journal of Clinical Pathology Suppl 40: 181-187
Sakata, T.; Kobayashi, K.; Katayama, Y.; Takada, T.; Matsuyama, T. 1991: Clinical evaluation of platelet antagonists on the ex vivo inhibitory effects of platelet aggregation Rinsho Byori. Japanese Journal of Clinical Pathology 39(3): 315-320
Appel, J.Z.; Alwayn, I.P.; Correa, L.E.; Cooper, D.K.; Robson, S.C. 2001: Modulation of platelet aggregation in baboons: implications for mixed chimerism in xenotransplantation. II. The effects of cyclophosphamide on pig peripheral blood progenitor cell-induced aggregation Transplantation 72(7): 1306-1310
Lechat, P. 1974: Periodical re-evaluation of the undesirable side effects of old drugs. An important mission of drug surveillance La Nouvelle Presse Medicale 3(24): 1571-1573
David, J.L. 1987: Mode of action and clinical evaluation of platelet aggregation inhibitors Revue Medicale de Liege 42(10): 526-533
Ionescu, S.D.; Sandru, V.; Leuciuc, E.; Manea, P.; Burdujan, A.; Tovarniţchi, S.; Cosovanu, A. 2002: Undesirable effects and interaction to angiotensin converting enzyme inhibitors therapy Revista Medico-Chirurgicala a Societatii de Medici Si Naturalisti Din Iasi 106(1): 128-131
Wu, S.; Zhao, Z.; Qi, H. 1990: Effects of tetrandrine on platelet aggregation, platelet adhesion and coagulation Zhongguo Zhong Yao Za Zhi 15(4): 233-235; 255-256